LOGO
LOGO

RTTNews

Top Stories

Do AI Chatbots Gossip About Users?

December 24, 2025 12:38 ET chatbot 24122025 lt

In a first-of-its-kind study, philosophers Joel Krueger and Lucy Osler from the University of Exeter explored whether AI chatbots gossip among themselves about the users. The topic about AI gossip first came to limelight when Microsoft's Bing chatbot, known as Sydney, told New York Times tech reporter...

Jeffs' Brands's Subsidiary Plans To Purse Uplisting On Nasdaq, Stock Up In Pre-Market

December 31, 2025 08:20 ET rttnewslogo20mar2024 lt

Jeffs' Brands Ltd (JFBR), Wednesday announced that its subsidiary Fort Technology Inc., a Global Consulting and IT Services company, is planning to pursue an uplisting on the Nasdaq Capital Market. This decision comes as Fort expects the uplisting to provide improved visibility as well as liquidity...

Global Economics Weekly Update - December 22 - 26, 2025

December 26, 2025 08:42 ET
Third quarter economic growth data from some major economies including the U.S. were the main news in this holiday shortened week. GDP growth and industrial production data from the U.S. helped to boost morale, while the consumer confidence survey results were less upbeat. In Europe, the quarterly economic growth data from the U.K. drew attention, while the minutes of the Australian central bank’s latest policy session was in focus in Asia.

Mixed Sentiment In Global Markets

December 19, 2025 06:09 ET trade 04122025 lt

Sentiment in global markets remains diverse as markets digest the cooling in U.S.CPI, the widely expected rate hike by Bank of Japan, as well as rising prospects of a Russia-Ukraine peace deal.

Biotech Stocks Facing FDA Decision In January 2026

December 30, 2025 03:21 ET calender1 30122025 lt

The regulatory landscape saw several historic firsts in terms of FDA approval in December. Among them are the approval of the first CAR T-cell therapy for marginal zone lymphoma and the introduction of TEMPO, a first-of-its-kind digital health pilot, to name a few. Let's take a look at the key regulatory decisions and anticipated approvals slated for January 2026.

Fed Minutes Highlight Mixed Views About Outlook For Interest Rates

December 30, 2025 14:26 ET building 17092025 lt

Following a split decision to lower interest rates by another quarter point last month, the minutes of the Federal Reserve's December meeting provided further clarification about officials' mixed views about the outlook for rates. The minutes revealed participants expressed a "range of views" about the restrictiveness of the Fed's current monetary policy stance.

  • Chicago Business Barometer Rebounds Much More Than Expected In December December 30, 2025 10:14 ET

    A report released by MNI Indicators on Tuesday showed a significant rebound by its reading on Chicago-area business activity in the month of December. MNI Indicators said its Chicago business barometer jumped to 43.5 in December after plunging to 36.3 in November. Economists had expected the index to rise to 39.5.

  • U.S. Pending Home Sales Surge Much More Than Expected In November December 29, 2025 10:11 ET

    A report released by the National Association of Realtors on Monday showed pending home sales in the U.S. shot up by much more than expected in the month of November. NAR said its pending home sales index spiked by 3.3 percent to 79.2 in November after surging by 2.4 percent to an upwardly revised 76.7 in October.

  • India Industrial Output Growth Rebounds December 29, 2025 06:52 ET

    India's industrial production rebounded the most in two years in November on strong growth in manufacturing and mining sectors, official data revealed on Monday. Industrial production registered an annual growth of 6.7 percent in November, following October's 0.5 percent increase, the Ministry of Statistics and Programme Implementation reported.

  • View More
Economic Calendar View More
DateIndicatorPeriodCountry

2025 Delivered Significant Victories For Disease Control: WHO

December 29, 2025 07:30 ET rttnewslogo20mar2024 lt

In a year-end analysis, World Health Organization claimed that amidst major funding cuts and increasing threats to science and solidarity, 2025 delivered significant victories for disease control and elimination across the globe. WHO noted that Maldives became the first country to achieve "triple...

  • Gut Risks Revealed: Emulsifiers Could Be Quietly Undermining Digestive Wellness December 29, 2025 07:30 ET

    Day after day, we unknowingly consume a cocktail of hidden food additives tucked into our favourite products—from silky salad dressings to indulgent ice creams and pillowy breads. Chief among them are emulsifiers, agents that coax oil and water into harmony, giving foods their appealing look, creamy...

  • New Variant Of Influenza Virus Surging, WHO Warns December 17, 2025 06:21 ET

    The World Health Organization has warned that amid an early start to the Northern Hemisphere influenza season, a new variant of the virus is rapidly gaining ground. Influenza and other respiratory viruses are surging, Dr Wenqing Zhang, Unit Head for Global Respiratory Threats at the Department of...

  • Heart Diseases Remain EU's Biggest Health Challenge: Report December 16, 2025 06:45 ET

    A new EU-funded report confirms that urgent bloc-level action is needed to tackle cardiovascular diseases, which is the European Union's number one killer. The 'State of Cardiovascular Health in the EU' report reveals that cardiovascular diseases are the leading cause of death and disability in the EU, accounting for one-third of all annual deaths and affecting over 60 million people. These fi

  • View More
Company Name
Drug
Event
Bristol Myers Squibb Co.
(BMY)
Breyanzi (sBLA)
12/05/2025
FDA decision to expand the use of Breyanzi as a potential treatment for adult patients with relapsed or refractory marginal zone lymphoma
Agios Pharmaceuticals, Inc.
(AGIO)
Pyrukynd (sNDA)
12/07/2025
FDA decision on Pyrukynd for the treatment of adult patients with non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia
GSK plc
( GSK, GSK.L, GS71.DE)
Blujepa (Gepotidacin) (sNDA)
12/11/2025
FDA decision on Gepotidacin for expanded use in treating uncomplicated urogenital gonorrhoea in patients 12 years of age and older.
Biocryst Pharmaceuticals Inc
(BCRX)
ORLADEYO (berotralstat) (NDA)
12/12/2025
FDA decision on ORLADEYO Oral Granules in pediatric patients with hereditary angioedema (HAE) aged 2 to 11 years
Milestone Pharmaceuticals Inc
(MIST)
CARDAMYST (Resubmitted NDA)
12/13/2025
FDA decision on CARDAMYST for the treatment of patients with paroxysmal supraventricular tachycardia

Wendy's Offers 1-Cent Jr. Bacon Cheeseburgers To Celebrate National Bacon Day

December 29, 2025 17:21 ET wendysv1 29122025 lt

Wendy's is giving customers a chance to score an ultra-cheap meal this week as part of its National Bacon Day celebration.

Canadian Market Down Marginally

December 31, 2025 10:35 ET rttnewslogo20mar2024 lt

Canadian stocks are turning in a mixed performance in lackluster trading Wednesday morning. With traders continuing to stay away on the sidelines due to year-end holidays, and the upcoming New Year Day, the market is moving in a very narrow range since the opening bell this morning.